This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A’Campo, L., Spliethoff-Kamminga, N., Timman, R & Roos., R (2009). Psychosocial Intervention in Huntington’s Disease: G06. Clinical Genetics, 76.A’CampoL., Spliethoff-KammingaN., TimmanR & Roos., R (2009). Psychosocial Intervention in Huntington’s Disease: G06. Clinical Genetics, 76.Search in Google Scholar
Anderson, K.E., van Duijn, E., Craufurd, D., Drazinic, C., Edmondson, M., Goodman, N., van Kammen, D., Loy, C., Priller, J. & Goodman, L. V. V.(2018). Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders. J Huntingtons Dis,7(3), 355-366. doi:10.3233/JHD-180293AndersonK.E., van DuijnE., CraufurdD., DrazinicC., EdmondsonM., GoodmanN., van KammenD., LoyC., PrillerJ. & GoodmanL. V. V.(2018). Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders. J Huntingtons Dis,7(3), 355-366. doi:10.3233/JHD-180293629459030040737Open DOISearch in Google Scholar
Bourne, C., Clayton, C., Murch, A. & Grant, J. (2006). Cognitive impairment and behavioural difficulties in patients with Huntington’s disease. Nursing Standard, 20(35).BourneC., ClaytonC., MurchA. & GrantJ. (2006). Cognitive impairment and behavioural difficulties in patients with Huntington’s disease. Nursing Standard, 20(35).10.7748/ns.20.35.41.s61Search in Google Scholar
Brown, A & Fisher, C. (2015). Optimising occupational performance through sensory modulation interventions: Case reports of two young adults diagnosed with juvenile Huntington’s disease. British Journal of Occupational Therapy, 78(12), p. 767-771.BrownA & FisherC. (2015). Optimising occupational performance through sensory modulation interventions: Case reports of two young adults diagnosed with juvenile Huntington’s disease. British Journal of Occupational Therapy, 78(12), p. 767-771.10.1177/0308022615569249Search in Google Scholar
Bruggen-Rufi, M., Jansen, I. & van Zwol, E. (2010)., J05 Multi-and interdisciplinary collaboration between the music therapist and other professionals in huntington’s patient care’, Journal of Neurology, Neurosurgery & Psychiatry, 81(1), p. A41-A41.Bruggen-RufiM., JansenI. & van ZwolE. (2010)., J05 Multi-and interdisciplinary collaboration between the music therapist and other professionals in huntington’s patient care’, Journal of Neurology, Neurosurgery & Psychiatry, 81(1), p. A41-A41.Search in Google Scholar
Burgunder, J.M., Guttman, M., Perlman, S., Goodman, N., van Kammen, D. P., &Good-man, L. (2011). An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease. PLoS Curr, 3, RRN1260. doi:10.1371/currents.RRN1260BurgunderJ.M., GuttmanM., PerlmanS., GoodmanN., van KammenD. P., &Good-manL. (2011). An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease. PLoS Curr, 3, RRN1260. doi:10.1371/currents.RRN1260316625621975581Open DOISearch in Google Scholar
Burgunder, J.M. (2013). Recent advances in the management of choreas. Ther Adv Neurol Disord,6(2), 117-127. doi:10.1177/1756285612471700BurgunderJ.M. (2013). Recent advances in the management of choreas. Ther Adv Neurol Disord,6(2), 117-127. doi:10.1177/1756285612471700358231123483632Open DOISearch in Google Scholar
Daveson, B. (2010). An Audit about Music Therapy Assessments and Recommendations for Adult Patients Suspected to be in a Low, Awareness State. Journal of Music Therapy, 47(4), p. 408-422.DavesonB. (2010). An Audit about Music Therapy Assessments and Recommendations for Adult Patients Suspected to be in a Low, Awareness State. Journal of Music Therapy, 47(4), p. 408-422.10.1093/jmt/47.4.40821488605Search in Google Scholar
Engel-Yeger, B. (2019). The involvement of altered sensory modulation in neurological conditions and its relevance to neurorehabilitation: a narrative literature review. Disability and rehabilitation, pp. 1-10.Engel-YegerB. (2019). The involvement of altered sensory modulation in neurological conditions and its relevance to neurorehabilitation: a narrative literature review. Disability and rehabilitation, pp. 1-10.Search in Google Scholar
Evan, K., Nizette, D. & O’Brien, A. (2016). Psychiatric and Mental Health Nursing, 4th edn, Mosby Elsevier, Sydney.EvanK., NizetteD. & O’BrienA. (2016). Psychiatric and Mental Health Nursing, 4th edn, Mosby Elsevier, Sydney.Search in Google Scholar
Fisher, C.A. & Brown, A. (2017). Sensory modulation intervention and behaviour support modification for the treatment of severe aggression in Huntington’s disease. A single case experimental design. Neuropsychological rehabilitation, 27(6), p. 891-903.FisherC.A. & BrownA. (2017). Sensory modulation intervention and behaviour support modification for the treatment of severe aggression in Huntington’s disease. A single case experimental design. Neuropsychological rehabilitation, 27(6), p. 891-903.10.1080/09602011.2015.109177926460553Search in Google Scholar
Fisher, C.A., Sewell, K., Brown, A. & Churchyard, A. (2014). Aggression in Huntington’s disease: a systematic review of rates of aggression and treatment methods, Journal of Huntington’s disease, 3(4), p. 319-332.FisherC.A., SewellK., BrownA. & ChurchyardA. (2014). Aggression in Huntington’s disease: a systematic review of rates of aggression and treatment methods, Journal of Huntington’s disease, 3(4), p. 319-332.10.3233/JHD-14012725575953Search in Google Scholar
Fitzgibbon, C. & O’Sullivan, J. (2018). Sensory Modulation - Change how you feel through using your senses, First edn, National Library of Australia Cataloguing, Brisbane.FitzgibbonC. & O’SullivanJ. (2018). Sensory Modulation - Change how you feel through using your senses, First edn, National Library of Australia Cataloguing, Brisbane.Search in Google Scholar
Frank, S. (2010). Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat, 6, 657-665. doi:10.2147/NDT.S6430FrankS. (2010). Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat, 6, 657-665. doi:10.2147/NDT.S6430295174920957126Open DOISearch in Google Scholar
Harding, R. Huntington’s disease clinical trial roundup. (2021). HDBuzz.https://en.hdbuzz.net/303HardingR. Huntington’s disease clinical trial roundup. (2021). HDBuzz.https://en.hdbuzz.net/303Search in Google Scholar
Huntington Study Group. (2006). Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology, 66(3), doi: 10.1212/01.wnl.0000198586.85250.13Huntington Study Group. (2006). Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology, 66(3), doi: 10.1212/01.wnl.0000198586.85250.1316476934Open DOISearch in Google Scholar
Johnson, A.C. & Paulsen, J.S. (2014). Understanding Behaviour In Huntington’s Disease: A Guide For Professionals. Hunting-ton’s Disease Society of America. http://hdsa.org/wp-content/uploads/2015/03/Understanding-Behavior.pdfJohnsonA.C. & PaulsenJ.S. (2014). Understanding Behaviour In Huntington’s Disease: A Guide For Professionals. Hunting-ton’s Disease Society of America. http://hdsa.org/wp-content/uploads/2015/03/Understanding-Behavior.pdfSearch in Google Scholar
Jongsma Jr, A. E., Peterson, L.M. & Bruce, T.J. (2021). The complete adult psychotherapy treatment planner, John Wiley & Sons.JongsmaJrA. E., PetersonL.M. & BruceT.J. (2021). The complete adult psychotherapy treatment planner, John Wiley & Sons.Search in Google Scholar
Juslin, P.N. & Sloboda, J. (2011). Handbook of music and emotion: Theory, research, applications, Oxford University Press.JuslinP.N. & SlobodaJ. (2011). Handbook of music and emotion: Theory, research, applications, Oxford University Press.Search in Google Scholar
Kieburtz K: Huntington Study Group. (1996). The Unified Huntington’s Disease Rating Scale: Reliability and Consistency. Mov Dis. 11, 136-142KieburtzK: Huntington Study Group. (1996). The Unified Huntington’s Disease Rating Scale: Reliability and Consistency. Mov Dis. 11, 136-14210.1002/mds.8701102048684382Search in Google Scholar
Lahiri, N. (2011). The genetic ‘gray area’ of Huntington’s disease: what does it all mean? HDBuzz. https://en.hdbuzz.net/027LahiriN. (2011). The genetic ‘gray area’ of Huntington’s disease: what does it all mean?HDBuzz. https://en.hdbuzz.net/027Search in Google Scholar
Langbehn, D.R., Hayden, M.R., Paulsen, J.S., & and the, P.-H. D. I. o. t. H. S. G. (2010). CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet, 153B(2), 397-408. doi:10.1002/ajmg.b.30992LangbehnD.R., HaydenM.R., PaulsenJ.S., & and the, P.-H. D. I. o. t. H. S. G. (2010). CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet, 153B(2), 397-408. doi:10.1002/ajmg.b.30992304880719548255Open DOISearch in Google Scholar
Lee, H-M., Chen, S-T. & Chen, S-J. (2010). Non-pharmacological treatments in a patient with dementia due to Huntington’s disease. The Journal of neuropsychiatry and clinical neurosciences, 22(2), p. 247. e217-247. e217.LeeH-M., ChenS-T. & ChenS-J. (2010). Non-pharmacological treatments in a patient with dementia due to Huntington’s disease. The Journal of neuropsychiatry and clinical neurosciences, 22(2), p. 247. e217-247. e217.10.1176/jnp.2010.22.2.247.e1720463131Search in Google Scholar
Lo, J., Reyes, A., Pulverenti, T.S., Rankin, T., Bartlett, D.M., Zaenker, P., Rowe, G., Feindel, K., Poudel, G., Georgiou-Karistianis, N., Ziman, M.R. & Cruickshank, T.M. (2020). Dual tasking impairmentsare associated with striatal pathology in Huntington’s disease. Annals of Clinical and Translational Neurology, 7(9), p. 1608-1619. doi:10.1002/acn3.51142LoJ., ReyesA., PulverentiT.S., RankinT., BartlettD.M., ZaenkerP., RoweG., FeindelK., PoudelG., Georgiou-KaristianisN., ZimanM.R. & CruickshankT.M. (2020). Dual tasking impairmentsare associated with striatal pathology in Huntington’s disease. Annals of Clinical and Translational Neurology, 7(9), p. 1608-1619. doi:10.1002/acn3.51142748091332794343Open DOISearch in Google Scholar
McColgan, P., & Tabrizi, S.J. (2018). Huntington’s disease: a clinical review. Eur J Neurol,25(1), 24-34. doi:10.1111/ene.13413McColganP., & TabriziS.J. (2018). Huntington’s disease: a clinical review. Eur J Neurol,25(1), 24-34. doi:10.1111/ene.1341328817209Open DOISearch in Google Scholar
McCusker, E.A., & Loy, C.T. (2017). Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing. Tremor Other Hyperkinet Mov (N Y), 7, 467. doi:10.7916/D8PK0TDDMcCuskerE.A., & LoyC.T. (2017). Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing. Tremor Other Hyperkinet Mov (N Y), 7, 467. doi:10.7916/D8PK0TDD562375428975045Open DOISearch in Google Scholar
Myers, R.H. (2004). Huntington’s Disease Genetics. The American Society for Experimental NeuroTherapeutics, Inc.1(2), 255-262. doi:10.1602/neurorx.1.2.255MyersR.H. (2004). Huntington’s Disease Genetics. The American Society for Experimental NeuroTherapeutics, Inc.1(2), 255-262. doi:10.1602/neurorx.1.2.25553494015717026Open DOISearch in Google Scholar
Novak, M.J. & Tabrizi, S.J. (2011). Hunting-ton’s disease: clinical presentation and treatment. International review of neurobiology, 98, p. 297-323.NovakM.J. & TabriziS.J. (2011). Hunting-ton’s disease: clinical presentation and treatment. International review of neurobiology, 98, p. 297-323.10.1016/B978-0-12-381328-2.00013-421907093Search in Google Scholar
Osler, W. (1893). Remarks On The Varieties Of Chronic Chorea, And A Report Upon Two Families Of The Hereditary Form, With One Autopsy. Journal of Nervous and Mental Disease. http://resource.nlm.nih.gov/101499811OslerW. (1893). Remarks On The Varieties Of Chronic Chorea, And A Report Upon Two Families Of The Hereditary Form, With One Autopsy. Journal of Nervous and Mental Disease. http://resource.nlm.nih.gov/10149981110.1097/00005053-189302000-00001Search in Google Scholar
Papanikolaou, A., Iakovidis, P., Lytras, D., Kottaras, I., Kottaras, A. & Chasapis, G. (2021). Physical therapy management of middle and late stage of Huntington’s disease.PapanikolaouA., IakovidisP., LytrasD., KottarasI., KottarasA. & ChasapisG. (2021). Physical therapy management of middle and late stage of Huntington’s disease.10.22271/27069567.2021.v3.i1h.183Search in Google Scholar
Paoli, R.A., Botturi, A., Ciammola, A., Silani, V., Prunas, C., Lucchiari, C., Zugnio, E. & Caletti, E. (2017). Neuropsychiatric Burden in Huntington’s Disease. Brain Sci, 7(6). doi:10.3390/brainsci7060067PaoliR.A., BotturiA., CiammolaA., SilaniV., PrunasC., LucchiariC., ZugnioE. & CalettiE. (2017). Neuropsychiatric Burden in Huntington’s Disease. Brain Sci, 7(6). doi:10.3390/brainsci7060067Open DOISearch in Google Scholar
Paulsen, J.S. (2011). Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep,11(5), 474-483. doi:10.1007/s11910-011-0215-xPaulsenJ.S. (2011). Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep,11(5), 474-483. doi:10.1007/s11910-011-0215-xOpen DOISearch in Google Scholar
Patrick, C. & Ritchie, S. (2020). Managing the Symptoms of Huntington’s disease. Prescriber, doi: 10.1002/psb.1824PatrickC. & RitchieS. (2020). Managing the Symptoms of Huntington’s disease. Prescriber, doi: 10.1002/psb.1824Open DOISearch in Google Scholar
Rawlins, M.D., Wexler, N.S., Wexler, A.R., Tabrizi, S.J., Douglas, I., Evans, S.J., & Smeeth, L. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology,46(2), 144-153. doi:10.1159/000443738RawlinsM.D., WexlerN.S., WexlerA.R., TabriziS.J., DouglasI., EvansS.J., & SmeethL. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology,46(2), 144-153. doi:10.1159/000443738Open DOISearch in Google Scholar
Reiner, A., Dragatsis, I., & Dietrich, P. (2011). Genetics and neuropathology of Huntington’s disease. Int Rev Neurobiol, 98, 325-372. doi:10.1016/B978-0-12-381328-2.00014-6ReinerA., DragatsisI., & DietrichP. (2011). Genetics and neuropathology of Huntington’s disease. Int Rev Neurobiol, 98, 325-372. doi:10.1016/B978-0-12-381328-2.00014-6Open DOISearch in Google Scholar
Rosenblatt, A., Ranen, N.G., Nance, M. A & Paulsen, J.S. (2010). A physician’s guide to the management of Huntington’s disease. Huntington’s Disease Society of America, New York.RosenblattA., RanenN.G., NanceM. A & PaulsenJ.S. (2010). A physician’s guide to the management of Huntington’s disease. Huntington’s Disease Society of America, New York.Search in Google Scholar
Rossi, G., & Oh, J.C. (2020). Management of Agitation in Huntington’s Disease: A Review of the Literature. Cureus, 12(8), e9748. doi:10.7759/cureus.9748RossiG., & OhJ.C. (2020). Management of Agitation in Huntington’s Disease: A Review of the Literature. Cureus, 12(8), e9748. doi:10.7759/cureus.9748Open DOISearch in Google Scholar
Sari, Y. (2011). Huntington’s Disease: From Mutant Huntington Protein to Neurotrophic Factor Therapy. Internal Journal of Biomedical Medical Science,7(2), 89-100. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154262/pdf/IJBS-7-89.pdfSariY. (2011). Huntington’s Disease: From Mutant Huntington Protein to Neurotrophic Factor Therapy. Internal Journal of Biomedical Medical Science,7(2), 89-100. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154262/pdf/IJBS-7-89.pdfSearch in Google Scholar
Schwartz, A.E., van Walsem, M. R., Brean, A. & Frich, J.C. (2019). Therapeutic use of music, dance, and rhythmic auditory cueing for patients with Huntington’s disease: a systematic review, Journal of Huntington’s disease, 8(4), p. 393-420.SchwartzA.E., van WalsemM. R., BreanA. & FrichJ.C. (2019). Therapeutic use of music, dance, and rhythmic auditory cueing for patients with Huntington’s disease: a systematic review, Journal of Huntington’s disease, 8(4), p. 393-420.10.3233/JHD-190370Search in Google Scholar
Spring, J.A., Baker, M., Dauya, L., Ewemade, I., Marsh, N., Patel, P., Scott, A., Stoy, N., Turner, H. & Viera, M. (2011). Gardening with Huntington’s disease clients-creating a programme of winter activities. Disability and rehabilitation,33(2), p. 159-164.SpringJ.A., BakerM., DauyaL., EwemadeI., MarshN., PatelP., ScottA., StoyN., TurnerH. & VieraM. (2011). Gardening with Huntington’s disease clients-creating a programme of winter activities. Disability and rehabilitation,33(2), p. 159-164.10.3109/09638288.2010.487924Search in Google Scholar
Tabrizi, S.J., Langbehn, D.R., Leavitt, B.R., Roos, R.A. C., Durr, A., Craufurd, D., Kennard, C., Hicks, S.L., Fox, N.C., Scahill, R.I., Borowsky, B., Tobin, A.J., Rosas, H.D., Johnson, H., Reilmann, R., Landwehrmeyer, B. & Stout, J.C. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: crisssectional analysis of baseline data. Lancet Neurol,8(9), 791-801. doi:10.1016/S1474-4422(09)70170-XTabriziS.J., LangbehnD.R., LeavittB.R., RoosR.A. C., DurrA., CraufurdD., KennardC., HicksS.L., FoxN.C., ScahillR.I., BorowskyB., TobinA.J., RosasH.D., JohnsonH., ReilmannR., LandwehrmeyerB. & StoutJ.C. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: crisssectional analysis of baseline data. Lancet Neurol,8(9), 791-801. doi:10.1016/S1474-4422(09)70170-XOpen DOISearch in Google Scholar
Tabrizi, S.J., Reilmann, R., Roos, R.A.C., Durr, A., Leavitt, B., Owen, G., Jones, R., Johnson, H., Draufurd, D., Hicks, S.L., Kennard, C., Landwehrmeyer, B., Stout, J.C., Borowsky, B., Scahill, R., Frost, C. & Langbehn, D.R. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet Neurology,11(1), 42-53. doi:10.1016/s1474-4422(11)70263-0TabriziS.J., ReilmannR., RoosR.A.C., DurrA., LeavittB., OwenG., JonesR., JohnsonH., DraufurdD., HicksS.L., KennardC., LandwehrmeyerB., StoutJ.C., BorowskyB., ScahillR., FrostC. & LangbehnD.R. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet Neurology,11(1), 42-53. doi:10.1016/s1474-4422(11)70263-0Open DOISearch in Google Scholar
Tabrizi, S.J., Ghosh, R., & Leavitt, B.R. (2019). Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease. Neuron,101(5), 801-819. doi:10.1016/j.neuron.2019.01.039TabriziS.J., GhoshR., & LeavittB.R. (2019). Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease. Neuron,101(5), 801-819. doi:10.1016/j.neuron.2019.01.039Open DOISearch in Google Scholar
Te Pou o te Whakaaro. (2011). Sensory Modulation in Mental Health Clinical Settings: A Review of the Literature.Te Pou o te Whakaaro. (2011). Sensory Modulation in Mental Health Clinical Settings: A Review of the Literature.Search in Google Scholar
The Huntington’s Disease Collaborative Research Group. (1993). A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington’s Disease Chromosomes. Cell.72(6), 971-983. doi:10.1016/0092-8674(93)90585-The Huntington’s Disease Collaborative Research Group. (1993). A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington’s Disease Chromosomes. Cell.72(6), 971-983. doi:10.1016/0092-8674(93)90585-Open DOISearch in Google Scholar
Uttley, L., Stevenson, M., Scope, A., Rawdin, A. & Sutton, A. (2015). The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC psychiatry, 15(1), p. 1-13.UttleyL., StevensonM., ScopeA., RawdinA. & SuttonA. (2015). The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC psychiatry, 15(1), p. 1-13.Search in Google Scholar
van Bruggen-Rufi, M. & Roos, R. (2015). The effect of music therapy for patients with Huntington’s disease: A systematic literature review. Journal of Literature and Art Studies, 5(1), p. 30-40.van Bruggen-RufiM. & RoosR. (2015). The effect of music therapy for patients with Huntington’s disease: A systematic literature review. Journal of Literature and Art Studies, 5(1), p. 30-40.Search in Google Scholar
van Bruggen-Rufi, M., Vink, A., Achterberg, W. & Roos, R. (2018). Improving quality of life in patients with Huntington’s disease through music therapy: A qualitative explorative study using focus group discussions. Nordic Journal of Music Therapy, 27(1), p. 44-66.van Bruggen-RufiM., VinkA., AchterbergW. & RoosR. (2018). Improving quality of life in patients with Huntington’s disease through music therapy: A qualitative explorative study using focus group discussions. Nordic Journal of Music Therapy, 27(1), p. 44-66.10.1080/08098131.2017.1284888Search in Google Scholar
van Duijn, E. (2017). Medical treatment of behavioral manifestations of Huntington disease. Handb Clin Neurol, 144, 129-139. doi:10.1016/B978-0-12-801893-4.00011-0van DuijnE. (2017). Medical treatment of behavioral manifestations of Huntington disease. Handb Clin Neurol, 144, 129-139. doi:10.1016/B978-0-12-801893-4.00011-0Open DOISearch in Google Scholar
Wexler, A., Wild, E.J., & Tabrizi, S.J. (2016). George Huntington: a legacy of inquiry, empathy and hope. Brain, 139(Pt 8), 2326-2333. doi:10.1093/brain/aww165WexlerA., WildE.J., & TabriziS.J. (2016). George Huntington: a legacy of inquiry, empathy and hope. Brain, 139(Pt 8), 2326-2333. doi:10.1093/brain/aww165Open DOISearch in Google Scholar
Wild, E.J., & Tabrizi, S.J. (2017). Therapies targeting DNA and RNA in Huntington’s disease. The Lancet Neurology,16(10), 837-847. doi:10.1016/s1474-4422(17)30280-6WildE.J., & TabriziS.J. (2017). Therapies targeting DNA and RNA in Huntington’s disease. The Lancet Neurology,16(10), 837-847. doi:10.1016/s1474-4422(17)30280-6Open DOISearch in Google Scholar
Williams, J. & Schutte, D. (2000) Genetic Testing and Mental Health: The Model of Huntington Disease. The Online Journal of Issues in Nursing. 5(3). www.nursingworld.org/MainMenuCategories/ANAMarketplace/ANAPeriodicals/OJIN/TableofContents/Volume52000/No3Sept00/HuntingtonDisease.aspxWilliamsJ. & SchutteD. (2000) Genetic Testing and Mental Health: The Model of Huntington Disease. The Online Journal of Issues in Nursing. 5(3). www.nursingworld.org/MainMenuCategories/ANAMarketplace/ANAPeriodicals/OJIN/TableofContents/Volume52000/No3Sept00/HuntingtonDisease.aspxSearch in Google Scholar
